Walla Al-Hertani, MD, MSc, FRCPC, FCCMG, FACMG

Dr. Walla Al-Hertani is a Biochemical Geneticist and Clinical Geneticist with expertise in inborn errors of metabolism (IEMs) and a special interest in Lysosomal Storage Diseases. Dr. Al-Hertani received her Doctor of Medicine degree from Dalhousie University in Halifax, Nova Scotia, followed by the completion of a Clinical Genetics residency at the University of Ottawa and a Biochemical Genetics fellowship at the Hospital for Sick Children (SickKids) and the University of Toronto. Dr. Al-Hertani practiced as a Medical Biochemical Geneticist and a Clinical Geneticist at the Montreal Children’s Hospital, and McGill University, followed by the Alberta Children’s Hospital in Calgary, Canada before relocating to Boston, where she was the Harvey Levy Endowed Chair in Metabolism and served as the Medical Director of the Metabolism Program, the Lysosomal Disorders (BoLD) Program and the Glycogen Storage Disorders Program. She is actively involved in a number of clinical trials investigating innovative therapies for IEMs and rare diseases. Dr. Walla Al-Hertani is currently the Division Chief, Metabolic Disorders Division at the Children’s Hospital of Orange County.